Demo Sign up Log In

Ligand Pharmaceuticals Inc (LGND)

Income Tax Expense

$40.74M

TTM · Period ending: Jun 30, 2026 · USD

LGND Income Tax Expense

Latest reported$40.74Mperiod endingJun 30, 2026

Latest reported$40.74Mperiod endingJun 30, 2026

LGND TTM Income Tax ($4.90M → $40.74M)

TTM income tax expense

High-resolution chart · PNG

LGND income tax expense history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Ligand Pharmaceuticals Inc Income Tax Expense — Trailing twelve months (TTM) (USD)
Period ending	Income Tax Expense (USD)
Jun 30, 2001	25,523,000
Mar 31, 2001	25,455,000
Dec 31, 2000	26,494,000
Sep 30, 2000	21,205,000
Jun 30, 2000	21,436,000
Mar 31, 2000	20,754,000
Dec 31, 1999	18,400,000
Sep 30, 1999	24,100,000
Jun 30, 1999	50,300,000
Mar 31, 1999	49,300,000
Dec 31, 1998	48,300,000
Sep 30, 1998	97,700,000
Jun 30, 1998	69,600,000
Mar 31, 1998	69,400,000
Dec 31, 1997	69,500,000
Sep 30, 1997	4,500,000
Jun 30, 1997	4,600,000
Mar 31, 1997	4,700,000
Dec 31, 1996	4,700,000
Sep 30, 1996	4,500,000
Jun 30, 1996	3,900,000
Mar 31, 1996	44,300,000
Dec 31, 1995	45,000,000
Sep 30, 1995	45,700,000
Jun 30, 1995	46,400,000
Mar 31, 1995	6,600,000
Dec 31, 1994	4,900,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.